5/3
08:07 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $225.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $225.00 price target on the stock.
5/3
08:02 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
5/2
03:02 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $200.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $200.00 price target on the stock.
5/2
02:39 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
5/2
02:39 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
4/8
11:23 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
4/8
11:23 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
3/27
10:08 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $234.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $234.00 price target on the stock.
3/27
10:06 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
3/27
10:06 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
3/5
01:01 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $395.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $395.00 price target on the stock.
2/23
12:07 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/21
09:51 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
2/21
09:51 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
2/20
01:11 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $165.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $165.00 price target on the stock.
2/20
12:29 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/20
10:58 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
2/20
10:58 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
2/20
10:20 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/20
10:20 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/16
01:45 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/16
01:45 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/16
12:02 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/16
12:02 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/16
11:51 am
alny
Rating for ALNY
Low
Report
Rating for ALNY